Published in PLoS One on December 19, 2012
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet (2013) 1.95
Genome-wide mapping of transcriptional start sites defines an extensive leaderless transcriptome in Mycobacterium tuberculosis. Cell Rep (2013) 1.48
Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment. Sci Rep (2015) 0.91
Global adaptation to a lipid environment triggers the dormancy-related phenotype of Mycobacterium tuberculosis. MBio (2014) 0.87
Identification of novel sRNAs in mycobacterial species. PLoS One (2013) 0.86
Key Hub and Bottleneck Genes Differentiate the Macrophage Response to Virulent and Attenuated Mycobacterium bovis. Front Immunol (2014) 0.86
Small RNAs in mycobacteria: an unfolding story. Front Cell Infect Microbiol (2014) 0.85
Transcriptional analysis of Deinococcus radiodurans reveals novel small RNAs that are differentially expressed under ionizing radiation. Appl Environ Microbiol (2014) 0.85
Revealing of Mycobacterium marinum transcriptome by RNA-seq. PLoS One (2013) 0.82
RNA-Seq analysis of Mycobacterium avium non-coding transcriptome. PLoS One (2013) 0.82
Identification of microRNA-size, small RNAs in Escherichia coli. Curr Microbiol (2013) 0.81
Relaxed selection drives a noisy noncoding transcriptome in members of the Mycobacterium tuberculosis complex. MBio (2014) 0.78
An automated approach for global identification of sRNA-encoding regions in RNA-Seq data from Mycobacterium tuberculosis. Acta Biochim Biophys Sin (Shanghai) (2016) 0.77
Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA. BMC Genomics (2015) 0.77
Comprehensive insights in the Mycobacterium avium subsp. paratuberculosis genome using new WGS data of sheep strain JIII-386 from Germany. Genome Biol Evol (2015) 0.76
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis. MBio (2017) 0.76
Ms1, a novel sRNA interacting with the RNA polymerase core in mycobacteria. Nucleic Acids Res (2014) 0.76
Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophages. World J Exp Med (2015) 0.75
Expression, maturation and turnover of DrrS, an unusually stable, DosR regulated small RNA in Mycobacterium tuberculosis. PLoS One (2017) 0.75
The Mycobacterium tuberculosis transcriptional landscape under genotoxic stress. BMC Genomics (2016) 0.75
Genome-wide identification and characterization of small RNAs in Rhodobacter capsulatus and identification of small RNAs affected by loss of the response regulator CtrA. RNA Biol (2017) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
Identifying biological themes within lists of genes with EASE. Genome Biol (2003) 31.72
Regulatory RNAs in bacteria. Cell (2009) 9.57
The primary transcriptome of the major human pathogen Helicobacter pylori. Nature (2010) 7.70
Evidence that microRNA precursors, unlike other non-coding RNAs, have lower folding free energies than random sequences. Bioinformatics (2004) 4.95
Regulation by small RNAs in bacteria: expanding frontiers. Mol Cell (2011) 4.68
An abundance of RNA regulators. Annu Rev Biochem (2005) 4.08
Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol (2011) 3.75
Widespread antisense transcription in Escherichia coli. MBio (2010) 2.96
CMfinder--a covariance model based RNA motif finding algorithm. Bioinformatics (2005) 2.96
Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect Immun (2003) 2.79
cis-antisense RNA, another level of gene regulation in bacteria. Microbiol Mol Biol Rev (2011) 2.78
Small noncoding RNAs controlling pathogenesis. Curr Opin Microbiol (2007) 2.76
Small RNAs controlling iron metabolism. Curr Opin Microbiol (2007) 2.54
Bacterial antisense RNAs: how many are there, and what are they doing? Annu Rev Genet (2010) 2.47
Regulatory RNA in bacterial pathogens. Cell Host Microbe (2010) 2.41
Primer extension analysis of RNA. Methods Enzymol (1989) 2.38
Multiple testing. Part I. Single-step procedures for control of general type I error rates. Stat Appl Genet Mol Biol (2004) 2.34
Experimental discovery of sRNAs in Vibrio cholerae by direct cloning, 5S/tRNA depletion and parallel sequencing. Nucleic Acids Res (2009) 2.25
Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol Microbiol (2000) 2.18
Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe (2008) 2.13
The transcriptionally active regions in the genome of Bacillus subtilis. Mol Microbiol (2009) 2.02
Identification of regulatory RNAs in Bacillus subtilis. Nucleic Acids Res (2010) 1.99
Immobilization of proteins in the nucleolus by ribosomal intergenic spacer noncoding RNA. Mol Cell (2012) 1.90
Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. FEMS Microbiol Lett (2004) 1.86
Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection. PLoS Pathog (2012) 1.84
Sequence-based analysis uncovers an abundance of non-coding RNA in the total transcriptome of Mycobacterium tuberculosis. PLoS Pathog (2011) 1.83
Identification of small RNAs in Mycobacterium tuberculosis. Mol Microbiol (2009) 1.75
From ribosome to riboswitch: control of gene expression in bacteria by RNA structural rearrangements. Crit Rev Biochem Mol Biol (2006) 1.70
Dynamics of transcriptional start site selection during nitrogen stress-induced cell differentiation in Anabaena sp. PCC7120. Proc Natl Acad Sci U S A (2011) 1.67
Small regulatory non-coding RNAs in bacteria: physiology and mechanistic aspects. Biol Cell (2009) 1.66
Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific. Infect Immun (2002) 1.51
Small RNAs establish gene expression thresholds. Curr Opin Microbiol (2008) 1.44
The macrophage marches on its phagosome: dynamic assays of phagosome function. Nat Rev Immunol (2009) 1.43
The sigma factors of Mycobacterium tuberculosis: regulation of the regulators. FEBS J (2009) 1.26
Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis. Nucleic Acids Res (2010) 1.26
The rRNA operons of Mycobacterium smegmatis and Mycobacterium tuberculosis: comparison of promoter elements and of neighbouring upstream genes. Microbiology (1996) 1.25
Transient requirement of the PrrA-PrrB two-component system for early intracellular multiplication of Mycobacterium tuberculosis. Infect Immun (2002) 1.24
Tuberculosis control is crucial to achieve the MDGs. Lancet (2010) 1.22
An overview of RNAs with regulatory functions in gram-positive bacteria. Cell Mol Life Sci (2009) 1.19
Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence. Infect Immun (2005) 1.18
Deep sequencing reveals as-yet-undiscovered small RNAs in Escherichia coli. BMC Genomics (2011) 1.16
Interaction fidelity in two-component signaling. Curr Opin Microbiol (2010) 1.15
WebGeSTer DB--a transcription terminator database. Nucleic Acids Res (2010) 1.14
Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med Genomics (2008) 1.10
RNIE: genome-wide prediction of bacterial intrinsic terminators. Nucleic Acids Res (2011) 1.09
Bacteriophage P4 immunity controlled by small RNAs via transcription termination. Mol Microbiol (1992) 1.08
Genetic control by cis-acting regulatory RNAs in Bacillus subtilis: general principles and prospects for discovery. Cold Spring Harb Symp Quant Biol (2006) 1.06
Mycobacterium tuberculosis rrn promoters: differential usage and growth rate-dependent control. J Bacteriol (1999) 1.03
RNA profiling in host-pathogen interactions. Curr Opin Microbiol (2007) 1.01
Genome-wide analysis of the intrinsic terminators of transcription across the genus Mycobacterium. Tuberculosis (Edinb) (2008) 1.01
Proteomic definition of the cell wall of Mycobacterium tuberculosis. J Proteome Res (2010) 1.01
A genome-wide identification analysis of small regulatory RNAs in Mycobacterium tuberculosis by RNA-Seq and conservation analysis. PLoS One (2012) 1.00
Roles of multiple promoters in transcription of ribosomal DNA: effects of growth conditions on precursor rRNA synthesis in mycobacteria. J Bacteriol (1998) 0.96
Rewiring two-component signal transduction with small RNAs. Curr Opin Microbiol (2011) 0.91
Analysis of microRNA-size, small RNAs in Streptococcus mutans by deep sequencing. FEMS Microbiol Lett (2011) 0.88
Chaperonin nomenclature. Mol Microbiol (1993) 0.86
Effect of PstS sub-units or PknD deficiency on the survival of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2010) 0.86
Regulating the regulators: How ribonucleases dictate the rules in the control of small non-coding RNAs. RNA Biol (2008) 0.85
The roles of pathogen small RNAs. J Cell Physiol (2011) 0.83
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science (2013) 5.64
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol (2006) 5.58
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science (2013) 5.34
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest (2009) 3.34
Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci U S A (2005) 2.84
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J Clin Invest (2007) 2.63
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J (2012) 2.58
Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol (2003) 2.56
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J (2012) 2.47
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med (2013) 2.39
The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res (2006) 2.36
Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A (2010) 2.12
Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med (2009) 2.08
A Semantic Web management model for integrative biomedical informatics. PLoS One (2008) 2.02
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy. Blood (2009) 1.88
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood (2010) 1.75
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J Clin Invest (2011) 1.66
The temporal response of the Mycobacterium tuberculosis gene regulatory network during growth arrest. Mol Syst Biol (2008) 1.56
Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun (2005) 1.49
Laparoscopic versus open colorectal surgery: cost-benefit analysis in a single-center randomized trial. Ann Surg (2005) 1.47
Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice. Blood (2012) 1.46
Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer (2005) 1.46
Carbon flux rerouting during Mycobacterium tuberculosis growth arrest. Mol Microbiol (2010) 1.43
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. EMBO Mol Med (2011) 1.39
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. Mol Ther (2009) 1.39
Mycobacterium tuberculosis FurA autoregulates its own expression. J Bacteriol (2003) 1.32
Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis (2007) 1.29
Early tuberculosis treatment monitoring by Xpert(R) MTB/RIF. Eur Respir J (2012) 1.28
Pristinamycin-inducible gene regulation in mycobacteria. J Biotechnol (2009) 1.28
Exposing the cancer genome atlas as a SPARQL endpoint. J Biomed Inform (2010) 1.25
Retinal nerve fiber layer thickness reproducibility using seven different OCT instruments. Invest Ophthalmol Vis Sci (2012) 1.23
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med (2014) 1.22
Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum (2004) 1.15
Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol (2006) 1.12
GenoType MTBDRsl performance on clinical samples with diverse genetic background. Eur Respir J (2012) 1.12
Molecular diversity of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mozambique. BMC Microbiol (2010) 1.09
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso. BMC Infect Dis (2009) 1.09
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. PLoS One (2010) 1.07
-174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res (2003) 1.05
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects. Blood (2006) 1.04
Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoring. Radiology (2010) 1.04
Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples? J Clin Microbiol (2012) 1.02
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood (2009) 1.01
Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology. Eur Radiol (2013) 1.00
The benefit of synthetic versus biological patch augmentation in the repair of posterosuperior massive rotator cuff tears: a 3-year follow-up study. Am J Sports Med (2014) 1.00
A genome-wide identification analysis of small regulatory RNAs in Mycobacterium tuberculosis by RNA-Seq and conservation analysis. PLoS One (2012) 1.00
Human herpesvirus 6A accelerates AIDS progression in macaques. Proc Natl Acad Sci U S A (2007) 0.98
AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy. Mol Ther (2011) 0.97
Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients. J Infect Dis (2012) 0.96
Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Surg Oncol (2002) 0.96
A mutation in polynucleotide phosphorylase from Escherichia coli impairing RNA binding and degradosome stability. Nucleic Acids Res (2004) 0.96
Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guérin vaccination. J Infect Dis (2003) 0.94
A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation. Pharmacogenet Genomics (2006) 0.94
Tuberculosis in Europe: a problem of drug resistance or much more? Expert Rev Respir Med (2010) 0.94
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Clin Infect Dis (2008) 0.92
Mycobacterium smegmatis RNase J is a 5'-3' exo-/endoribonuclease and both RNase J and RNase E are involved in ribosomal RNA maturation. Mol Microbiol (2011) 0.92
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors. PLoS Comput Biol (2011) 0.92
Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. J Magn Reson Imaging (2013) 0.91
The katG mRNA of Mycobacterium tuberculosis and Mycobacterium smegmatis is processed at its 5' end and is stabilized by both a polypurine sequence and translation initiation. BMC Mol Biol (2008) 0.90
Drug resistance in Mycobacterium tuberculosis: molecular mechanisms challenging fluoroquinolones and pyrazinamide effectiveness. Chest (2015) 0.90
Tuberculosis: lights and shadows in the current diagnostic landscape. New Microbiol (2013) 0.90
Availability of anti-tuberculosis drugs in Europe. Eur Respir J (2012) 0.90
Retroviral integration process in the human genome: is it really non-random? A new statistical approach. PLoS Comput Biol (2008) 0.89
Factors contributing to epidemic MRSA clones replacement in a hospital setting. PLoS One (2012) 0.89
First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy. Clin Infect Dis (2010) 0.89
Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg. Eur Radiol (2014) 0.89
Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis. Am J Respir Crit Care Med (2006) 0.87
Transcriptional characterization of the antioxidant response of Mycobacterium tuberculosis in vivo and during adaptation to hypoxia in vitro. Tuberculosis (Edinb) (2007) 0.87
WhiB5, a transcriptional regulator that contributes to Mycobacterium tuberculosis virulence and reactivation. Infect Immun (2012) 0.87
miRNA signatures in sera of patients with active pulmonary tuberculosis. PLoS One (2013) 0.86
Lymphadenectomy in patients with gastric cancer. A critical review. Suppl Tumori (2003) 0.86
The roles of microRNAs on tuberculosis infection: meaning or myth? Tuberculosis (Edinb) (2013) 0.86
Mycobacterium tuberculosis RNA polymerase-binding protein A (RbpA) and its interactions with sigma factors. J Biol Chem (2013) 0.85
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors. PLoS One (2013) 0.84
Antitumor IgE adjuvanticity: key role of Fc epsilon RI. J Immunol (2009) 0.84
Mycobacterium tuberculosis Beijing genotype is associated with HIV infection in Mozambique. PLoS One (2013) 0.82
RNase E and polyadenyl polymerase I are involved in maturation of CI RNA, the P4 phage immunity factor. J Mol Biol (2002) 0.82
Isolation of conditional expression mutants in Mycobacterium tuberculosis by transposon mutagenesis. Tuberculosis (Edinb) (2011) 0.81
Bacteriophage P4 Vis protein is needed for prophage excision. Virology (2004) 0.80